type 2 diabetes mellitus (t2dm)
Showing 1 - 25 of 34
Type 2 Diabetes (T2DM) Trial in Montréal (ALN-KHK, Placebo)
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
- ALN-KHK
- Placebo
-
Montréal, Quebec, CanadaClinical Trial Site
Mar 7, 2023
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial in Japan (Dulaglutide, Biguanide (BG), Sulfonylurea (SU))
Active, not recruiting
- Diabetes Mellitus
- +6 more
- Dulaglutide
- +6 more
-
Nagoya-shi, Aichi, Japan
- +43 more
Jan 16, 2023
Type 2 Diabetes (T2DM) Trial (Endovascular Denervation System (Netrod))
Not yet recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular Denervation System (Netrod)
- (no location specified)
Jan 5, 2023
Type 2 Diabetes (T2DM) Trial in Nanjing (Endovascular denervation System (Generator and Catheter ))
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Endovascular denervation System (Generator and Catheter )
-
Nanjing, Jiangsu, ChinaZhongda Hospital, Southeast University
Jan 2, 2023
Persistence to Basal Insulin in Type 2 Diabetes
Not yet recruiting
- Type 2 Diabetes Mellitus (T2DM)
-
Chilly-Mazarin, FranceInvestigational Site Number :
Nov 16, 2022
Type 2 Diabetes (T2DM) Trial in Germany
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
-
Germany, GermanyInvestigational site
Nov 21, 2022
Food Insecurities, Cardiometabolic Comorbidities, HIV Trial in Winston-Salem (weCare/Secure, Usual Care)
Recruiting
- Food Insecurities
- +4 more
- weCare/Secure
- Usual Care
-
Winston-Salem, North CarolinaWake Forest Health Sciences
Nov 15, 2022
Non-alcoholic Steatohepatitis, Type 2 Diabetes (T2DM), Chronic Kidney Disease Trial in Ruddington (cotadutide solution for
Completed
- Non-alcoholic Steatohepatitis
- +2 more
- cotadutide solution for injection
-
Ruddington, United KingdomResearch Site
Sep 30, 2022
Chronic Kidney Disease (CKD), Type 2 Diabetes (T2DM), Coronary Artery Disease (CAD) Trial in Jacksonville (Clopidogrel,
Active, not recruiting
- Chronic Kidney Disease (CKD)
- +2 more
- Clopidogrel
- Clopidogrel active metabolite
-
Jacksonville, FloridaUniversity of Florida Jacksonville
Aug 5, 2022
Fatty Liver, Nonalcoholic, NAFLD, Nonalcoholic Fatty Liver Disease Trial in United States (HTD1801, Placebo)
Type 2 Diabetes (T2DM) Trial in Tuebingen (Dapagliflozin (Forxiga®), Hydrochlorothiazide 25 mg, Placebo matching Dapagliflozin)
Withdrawn
- Type 2 Diabetes Mellitus (T2DM)
- Dapagliflozin (Forxiga®)
- +2 more
-
Tuebingen, GermanyUniversity Hospital Tuebingen, Otfried-Mueller Str. 10
Dec 8, 2021
Type 2 Diabetes (T2DM) Trial in Beijing (GLP-1 receptor agonist, Placebo)
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
- GLP-1 receptor agonist
- Placebo
-
Beijing, Beijing, ChinaBeijing University People's Hospital
Oct 17, 2021
Type 2 Diabetes (T2DM) Trial in La Jolla (Medical Assistant Health Coaching)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- Medical Assistant Health Coaching
-
La Jolla, CaliforniaScripps Whittier Diabetes Institute
Sep 20, 2021
Multiple Electrode Aggregometry & Clopidogrel Resistance
Completed
- Type 2 Diabetes Mellitus (T2DM)
- +2 more
-
Athens, Haidari, Athens, Greece
- +2 more
Apr 8, 2021
Type 2 Diabetes (T2DM), Nonalcoholic Steatohepatitis Trial in Gainesville (Pioglitazone, Placebo)
Recruiting
- Type 2 Diabetes Mellitus (T2DM)
- Nonalcoholic Steatohepatitis
- Pioglitazone
- Placebo
-
Gainesville, FloridaUniversity of Florida
Jan 11, 2021
Type 2 Diabetes (T2DM) Trial in Miami (LIK066, Placebo)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- LIK066
- Placebo
-
Miami, FloridaNovartis Investigative Site
Dec 11, 2020
Type 2 Diabetes (T2DM) Trial in Phoenix (Saxagliptin, Placebo)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- Saxagliptin
- Placebo
-
Phoenix, ArizonaCarl T. Hayden VA Medical Hospital
Mar 11, 2020
Type 2 Diabetes (T2DM) Trial in Miami (PB-119 100 µg+ Glucophage®, PB-119 150 µg+ Glucophage®, PB-119 200 µg+ Glucophage®)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- PB-119 100 μg+ Glucophage®
- +3 more
-
Miami, FloridaClinical Pharmacology of Miami
Jan 21, 2020
Type 2 Diabetes (T2DM) Trial in Kazan, Moscow (Lifestyle intervention)
Completed
- Type 2 Diabetes Mellitus (T2DM)
- Lifestyle intervention
-
Kazan, Russian Federation
- +1 more
Apr 11, 2019
Type 2 Diabetes (T2DM) Trial in Abbotsford, Vancouver (Group Appointments, Individual Appointments (IAs))
Unknown status
- Type 2 Diabetes Mellitus (T2DM)
- Group Appointments
- Individual Appointments (IAs)
-
Abbotsford, British Columbia, Canada
- +1 more
Nov 20, 2017
Coronary Heart Disease, Acute Coronary Syndrome, Impaired Glucose Tolerance Trial in China, Hong Kong (Acarbose, Matching
Completed
- Coronary Heart Disease
- +3 more
- Acarbose
- Matching Placebo
-
Hefei, Anhui, China
- +176 more
Jul 21, 2017
Type 2 Diabetes (T2DM) Trial in Canada, United States (CJC-1134-PC Injection, Weekly for CJC-1134-PC Injection)
Terminated
- Type 2 Diabetes Mellitus (T2DM)
- CJC-1134-PC Injection
- Weekly placebo for CJC-1134-PC Injection
-
Phoenix, Arizona
- +21 more
Jun 21, 2017
Healthy, Type 2 Diabetes (T2DM) Trial in South Miami, Singapore (LY3298176, Placebo, Dulaglutide)
Completed
- Healthy
- Type 2 Diabetes Mellitus (T2DM)
- LY3298176
- +2 more
-
South Miami, Florida
- +1 more
Jun 28, 2017